UBS Group’s Zimmer Biomet ZBH Stock Holding History

UBS Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,100	Closed	-$818K	–	11274
2025 Q4	$818K	Buy	+9,100	New	+$863K	﹤0.01%	5738
2025 Q3	–	Sell	-5,500	Closed	-$502K	–	11034
2025 Q2	$502K	Buy	+5,500	New	+$532K	﹤0.01%	6002
2025 Q1	–	Sell	-12,700	Closed	-$1.34M	–	10783
2024 Q4	$1.34M	Hold	12,700	–	–	﹤0.01%	5085
2024 Q3	$1.37M	Sell	12,700 -3,000	-19%	-$327K	﹤0.01%	4350
2024 Q2	$1.7M	Sell	15,700 -4,600	-23%	-$542K	﹤0.01%	3934
2024 Q1	$2.68M	Buy	+20,300	New	+$2.54M	﹤0.01%	3644
2018 Q2	–	Sell	-36,565	Closed	-$3.87M	–	8304
2018 Q1	$3.87M	Sell	36,565 -9,579	-21%	-$1.11M	﹤0.01%	2546
2017 Q4	$5.41M	Buy	+46,144	New	+$5.22M	﹤0.01%	2276
2017 Q3	–	Sell	-35,020	Closed	-$4.37M	–	8043
2017 Q2	$4.37M	Buy	+35,020	New	+$4.15M	﹤0.01%	2270
2016 Q2	–	Sell	-69,113	Closed	-$7.16M	–	8012
2016 Q1	$7.16M	Buy	+69,113	New	+$6.69M	﹤0.01%	1562
2015 Q2	–	Sell	-103	Closed	-$12K	–	8898
2015 Q1	$12K	Buy	+103	New	+$11.8K	﹤0.01%	7506

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group's ZBH Position: Q1 2026 in Review

UBS Group increased its Zimmer Biomet (ZBH) stake by 68% in Q1 2026, buying an estimated $51M and bringing the position to 1,373,365 shares worth $124M. The position accounts for 0.02% of the portfolio, ranked #891.

UBS Group first reported a position in ZBH in Q4 2014 and has held it in 46 quarters since. The position peaked at $134M in Q2 2017. 913 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

UBS Group held 1,373,365 shares of Zimmer Biomet worth $124M as of Q1 2026.
UBS Group bought 556,119 Zimmer Biomet shares in Q1 2026, an estimated $51M.
Zimmer Biomet made up 0.02% of UBS Group's portfolio in Q1 2026, its #891 holding.
UBS Group first reported a position in Zimmer Biomet in Q4 2014 and has held it in 46 quarters since.
UBS Group's Zimmer Biomet position peaked at $134M in Q2 2017.
913 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.